Based on our previous observation that oncostatin M (OSM) treatment induces HIF-1 α expression in hepatocytes under normoxia, we first investigated whether the OSM-mediated upregulation of HIF-1 α is a general effect for hepatocytes and hepatoma cells [9]. This evidence concerns the gene SETD2 and hepatocellular carcinoma.